Description
Acalabrutinib, marketed under the brand name CALQUENCE, It is an prescription medication that has been approved pralatrexate (brand name Folotyn) on September 24, 2009. Pralatrexate was the first drug approved to treat relapsed or refractory peripheral T-cell lymphoma (PTCL), a type of non-Hodgkins lymphoma.
What is CALQUENCE (Acalabrutinib) ?
CALQUENCE is a kinase inhibitor indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. This indication is approved under accelerated approval based on overall response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.
Source Content From US FDA
How to order approved “CALQUENCE (acalabrutinib) for Capsules” Medicine?
CALQUENCE (Acalabrutinib) Capsules is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing CALQUENCE and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
